Journal article
Perilipin 5 regulates islet lipid metabolism and insulin secretion in a cAMP-dependent manner: implication of its role in the postprandial insulin secretion
Diabetes (New York, N.Y.), Vol.64(4), pp.1299-1310
04/2015
DOI: 10.2337/db14-0559
PMCID: PMC4375085
PMID: 25392244
Abstract
Elevation of circulating fatty acids (FA) during fasting supports postprandial (PP) insulin secretion that is critical for glucose homeostasis and is impaired in diabetes. We tested our hypothesis that lipid droplet (LD) protein perilipin 5 (PLIN5) in β-cells aids PP insulin secretion by regulating intracellular lipid metabolism. We demonstrated that PLIN5 serves as an LD protein in human islets. In vivo, Plin5 and triglycerides were increased by fasting in mouse islets. MIN6 cells expressing PLIN5 (adenovirus [Ad]-PLIN5) and those expressing perilipin 2 (PLIN2) (Ad-PLIN2) had higher [(3)H]FA incorporation into triglycerides than Ad-GFP control, which support their roles as LD proteins. However, Ad-PLIN5 cells had higher lipolysis than Ad-PLIN2 cells, which increased further by 8-Br-cAMP, indicating that PLIN5 facilitates FA mobilization upon cAMP stimulation as seen postprandially. Ad-PLIN5 in islets enhanced the augmentation of glucose-stimulated insulin secretion by FA and 8-Br-cAMP in G-protein-coupled receptor 40 (GPR40)- and cAMP-activated protein kinase-dependent manners, respectively. When PLIN5 was increased in mouse β-cells in vivo, glucose tolerance after an acute exenatide challenge was improved. Therefore, the elevation of islet PLIN5 during fasting allows partitioning of FA into LD that is released upon refeeding to support PP insulin secretion in cAMP- and GPR40-dependent manners.
Details
- Title: Subtitle
- Perilipin 5 regulates islet lipid metabolism and insulin secretion in a cAMP-dependent manner: implication of its role in the postprandial insulin secretion
- Creators
- Michelle B Trevino - Department of Internal Medicine, Strelitz Diabetes Center, Eastern Virginia Medical School, Norfolk, VAYui Machida - Department of Internal Medicine, Strelitz Diabetes Center, Eastern Virginia Medical School, Norfolk, VADaniel R Hallinger - Department of Internal Medicine, Strelitz Diabetes Center, Eastern Virginia Medical School, Norfolk, VAEden Garcia - Department of Internal Medicine, Strelitz Diabetes Center, Eastern Virginia Medical School, Norfolk, VAAaron Christensen - Department of Internal Medicine, Strelitz Diabetes Center, Eastern Virginia Medical School, Norfolk, VASucharita Dutta - Leroy T. Canoles Cancer Research Center, Eastern Virginia Medical School, Norfolk, VADavid A Peake - Thermo Fisher Scientific, San Jose, CAYasuhiro Ikeda - Department of Molecular Medicine, Mayo Clinic, Rochester, MNYumi Imai - Department of Internal Medicine, Strelitz Diabetes Center, Eastern Virginia Medical School, Norfolk, VA imaiy@evms.edu
- Resource Type
- Journal article
- Publication Details
- Diabetes (New York, N.Y.), Vol.64(4), pp.1299-1310
- DOI
- 10.2337/db14-0559
- PMID
- 25392244
- PMCID
- PMC4375085
- ISSN
- 0012-1797
- eISSN
- 1939-327X
- Grant note
- R01 DK090490 / NIDDK NIH HHS R01-DK-090490 / NIDDK NIH HHS R01-DK-090490-02W1 / NIDDK NIH HHS
- Language
- English
- Date published
- 04/2015
- Academic Unit
- Endocrinology and Metabolism; Internal Medicine
- Record Identifier
- 9984094873102771
Metrics
18 Record Views